Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.

BACKGROUND Fibroblast growth factor 21 (FGF21) is a regulator of carbohydrate and lipid metabolism; however, the regulation of Fgf21 gene expression by diet remains incompletely understood. OBJECTIVE We investigated the effect of a high-carbohydrate (HC) liquid diet, with and without supplementation with a lipid emulsion (LE), and of a high-fat diet (HFD) compared with a low-fat diet (LFD) on the regulation of Fgf21 gene expression in the liver of intact mice. METHODS C57BL/6 male mice were fed standard feed pellets (SFPs), a purified HC liquid diet (adequate in calories and protein), or an HC liquid diet containing an LE at either 4% or 13.5% of energy for 5 wk (Expt. 1) or 1 wk (Expt. 2). In Expt. 3, mice were fed a purified LFD (∼10% fat) or HFD (∼60% fat) or were fed an HFD and given access to a running wheel for voluntary exercise for 16 wk. RESULTS Fgf21 mRNA in liver and FGF21 protein in plasma were increased by 3.5- to 7-fold in HC mice compared with SFP mice (P < 0.001), whereas the LE dose-dependently attenuated the induction of Fgf21 expression (P < 0.05). After 16 wk, hepatic Fgf21 mRNA did not differ between LFD and HFD mice but was dramatically reduced in the HFD+exercise group to <20% of the level in the HFD group (P < 0.0001). CONCLUSIONS In mice, hepatic Fgf21 expression was upregulated by 1 and 5 wk of feeding a lipogenic HC diet but not by 16 wk of feeding an obesogenic HFD, whereas the addition of fat as an LE to the HC formula significantly reduced Fgf21 gene expression and the plasma FGF21 protein concentration. Our results support a strong and reversible response of hepatic Fgf21 expression to shifts in dietary glucose intake.

[1]  J. Lambert,et al.  Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells. , 2014, Metabolism: clinical and experimental.

[2]  G. Bray,et al.  FGF21 is an endocrine signal of protein restriction. , 2014, The Journal of clinical investigation.

[3]  D. Moller,et al.  FGF21-based pharmacotherapy – potential utility for metabolic disorders , 2014, Trends in Endocrinology & Metabolism.

[4]  J. Lambert,et al.  Voluntary exercise and green tea enhance the expression of genes related to energy utilization and attenuate metabolic syndrome in high fat fed mice. , 2014, Molecular nutrition & food research.

[5]  A. Ross,et al.  Lipid emulsion administered intravenously or orally attenuates triglyceride accumulation and expression of inflammatory markers in the liver of nonobese mice fed parenteral nutrition formula. , 2013, The Journal of nutrition.

[6]  W. Jia,et al.  Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology , 2013, Frontiers of Medicine.

[7]  R. Selgas,et al.  Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. , 2012, European journal of endocrinology.

[8]  R. Rector,et al.  Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction. , 2012, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[9]  C. Aguilar-Salinas,et al.  Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels , 2012, PloS one.

[10]  S. Kliewer,et al.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.

[11]  A. Shanafelt,et al.  Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases , 2012, BioDrugs.

[12]  S. Kliewer,et al.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.

[13]  J. Flier,et al.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.

[14]  Jason K. Kim,et al.  Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice , 2009, Diabetes.

[15]  D. Moller,et al.  Fibroblast growth factor 21 corrects obesity in mice. , 2008, Endocrinology.

[16]  M. Eriksson,et al.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. , 2008, Cell metabolism.

[17]  T. Lundåsen,et al.  PPARα is a key regulator of hepatic FGF21 , 2007 .

[18]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[19]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[20]  T. Lundåsen,et al.  PPARalpha is a key regulator of hepatic FGF21. , 2007, Biochemical and biophysical research communications.

[21]  H. Towle,et al.  ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.

[22]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[23]  M. Konishi,et al.  Identification of a novel FGF, FGF-21, preferentially expressed in the liver. , 2000, Biochimica et biophysica acta.

[24]  K. Kawano,et al.  Spontaneous Long-Term Hyperglycemic Rat With Diabetic Complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain , 1992, Diabetes.

[25]  J. Manning,et al.  The Determination of Triglycerides in Plasma and Tissues , 1968 .

[26]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.